Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5692338 | Contraception | 2017 | 24 Pages |
Abstract
Carbamazepine use significantly reduces serum etonogestrel concentrations in women using an etonogestrel contraceptive implant, with the majority of participants having etonogestrel concentrations below the threshold for ovulatory suppression. Our findings suggest that treatment with carbamazepine might increase the risk of pregnancy in etonogestrel implant users.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Aaron Lazorwitz, Anne Davis, Maryke Swartz, Maryam Guiahi,